Showing results (1-10 of 398) with videos related to
Sort By:
Pageof 40
Current Pharmaceutical Design|July 20, 2005
Pharmacological management of acutely agitated schizophrenic patientsL San, B Arranz, R EscobarActas Espanolas De Psiquiatria|May 3, 2001
[Genetic dysfunction of the serotonin receptor 5-HT2A in psychiatric disorders]B Arranz, P Rosel, N Ramírez, et al.Actas Espanolas De Psiquiatria|April 3, 2007
[Course and prognosis of a case of central pontine myelinolysis in eating behavior disorder]N Ramírez, B Arranz, C Martín, et al.Actas Espanolas De Psiquiatria|February 14, 2004
[Rhabdomyolysis due to polydipsia in a patient with psychotic disorder]N Ramírez, B Arranz, S Sarro, et al.Actas Espanolas De Psiquiatria|March 29, 2001
[Electroconvulsive therapy and serotonergic system]N Ramírez, B Arranz, R M Dueñas, et al.Actas Espanolas De Psiquiatria|July 27, 2001
[Instruments of depression assessment in schizophrenia]N Ramírez, S Sarro, B Arranz, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Characterization of the 5-HT4 binding site in human brainB Arranz, P Rosel, L San, et al.Journal of Substance Abuse Treatment|September 29, 1998
Monitoring patterns of substance use in drug-dependent patientsL San, M Torrens, J Tato, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 16, 2006
A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patientsL San, B Arranz, I Querejeta, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|October 21, 1999
Platelet serotonergic binding sites in alcohol-dependent patientsB Arranz, P Rosel, S Sarró, et al.Pageof 40